PODD · Insulet Corp.
$158.252026-07-21Sector: Healthcare; Industry: Medical - Devices; Sub-Industry: Health Care Equipment
Intrinsic Value Range Comparison · Mulya.ai
R&D capitalized (5yr)Base · active
$218
+37.7% vs market
Mulya.ai vs Analyst IV Comparison?
Mulya.ai IV range ($144 · $303) Analysts Range ($190 · $280) Fundamentals · historical + forward · baseitalics = DCF projection
| Period | Revenue | Rev Gr ? | Ops M% ? | Tax Rate ? | NOPAT ? | Reinvest ? | FCFF ? | WACC% ? | PV FCFF ? | ROIC ? | Inv. Cap ? | EPS ? | P/E |
|---|
| 2024.Q1 | $1.7B | — | 16.3% | 4.5% | $265MM | −$212MM | $52MM | 8.8% | — | 13.6% | $1.9B | $2.94 | — |
| 2024.Q4 | $1.7B | 0.0% | 16.3% | 0.0% | $386MM | −$155MM | $231MM | 10.8% | — | 18.9% | $2.1B | $2.94 | — |
| 2025.Q1 | $2.1B | 22.1% | 18.8% | 0.0% | $533MM | −$211MM | $322MM | 9.2% | — | 24.1% | $2.3B | $5.96 | — |
| 2025.Q4 | $2.1B | 0.0% | 18.8% | 27.2% | $283MM | −$221MM | $62MM | 10.8% | — | 12.3% | $2.3B | $5.96 | — |
| 2026.Q1 | $2.9B | 40.0% | 22.0% | 25.1% | $478MM | −$254MM | $224MM | 9.1% | — | 19.8% | $2.5B | $4.31 | 17.4 |
| italics below = DCF projection · 10yr Rev CAGR: 11.8% |
| 2027.Q1 | $3.5B | +20.9% | 27.7% | 24.6% | $733MM | −$543MM | $190MM | 9.1% | $174MM | 26.4% | $3.0B | $6.59 | 24.0 |
| 2028.Q1 | $4.2B | +18.6% | 26.6% | 24.1% | $840MM | −$608MM | $232MM | 9.0% | $195MM | 25.1% | $3.7B | $7.88 | 20.1 |
| 2029.Q1 | $4.9B | +17.9% | 25.5% | 23.6% | $957MM | −$724MM | $233MM | 9.0% | $180MM | 23.8% | $4.4B | $9.38 | 16.9 |
| 2030.Q1 | $5.7B | +15.2% | 24.4% | 23.1% | $1.1B | −$755MM | $307MM | 8.9% | $217MM | 22.4% | $5.1B | $10.90 | 14.5 |
| 2031.Q1 | $6.3B | +11.5% | 22.2% | 22.6% | $1.1B | −$687MM | $399MM | 8.9% | $259MM | 19.8% | $5.8B | $12.29 | 12.9 |
|
| Term. Yr+ | $9.2B | 4.1% | 22.2% | 20.0% | $1.6B | −$370MM | $1.3B | 8.6% | $12.1B | 18.2% | — | — | — |
Active scenario IV: $218 (+37.7% vs market)